Feb 20 (Reuters) - Pfizer (PFE.N), opens new tab said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and ...

NEW YORK/TOKYO -- Pfizer will end global development and commercialization of Beqvez, a gene therapy for hemophilia, after the drugmaker dropped its other similar treatment for the disorder in ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Bluebird makes three gene therapies: Zynteglo for beta thalassemia, Lyfgenia for sickle cell disease and Skysona for cerebral adrenoleukodystrophy. The entire gene therapy field is facing tough ...

Gene regulation refers to the mechanisms that act to induce or repress the expression of a gene. These include structural and chemical changes to the genetic material, binding of proteins to ...

SMi are delighted to welcome the expertise from a senior panel of big biotech's and pharma organisations, as well as regulatory bodies, at the inaugural Cell & Gene Therapy 2018 conference ...

Since then, numerous companies and research institutions have worked fiercely to refine genetic editing techniques and develop commercially viable gene-editing therapies. The initial applications ...

Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable ...

President Donald Trump has revoked security clearances for Antony Blinken, the former secretary of state, and Jake Sullivan, the former national security adviser, White House officials said on ...

Its proprietary technology combines flow cytometry with whole transcriptome sequencing to evaluate biomarkers, gene expression, cell states, cellular composition, and immunophenotypes. The AI ...